BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 20185928)

  • 1. Effects of TGF-beta on podocyte growth and disease progression in proliferative podocytopathies.
    Lee HS; Song CY
    Kidney Blood Press Res; 2010; 33(1):24-9. PubMed ID: 20185928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease.
    Lee HS
    Cell Tissue Res; 2012 Jan; 347(1):129-40. PubMed ID: 21541658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF-binding protein-3 modulates TGF-beta/BMP-signaling in glomerular podocytes.
    Peters I; Tossidou I; Achenbach J; Woroniecki R; Mengel M; Park JK; Paschy M; de Groot K; Haller H; Schiffer M
    J Am Soc Nephrol; 2006 Jun; 17(6):1644-56. PubMed ID: 16672319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-beta concentration specifies differential signaling profiles of growth arrest/differentiation and apoptosis in podocytes.
    Wu DT; Bitzer M; Ju W; Mundel P; Böttinger EP
    J Am Soc Nephrol; 2005 Nov; 16(11):3211-21. PubMed ID: 16207831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The spectrum of focal segmental glomerulosclerosis: new insights.
    D'Agati VD
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):271-81. PubMed ID: 18408478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic role of TGF-β in the progression of podocyte diseases.
    Lee HS
    Histol Histopathol; 2011 Jan; 26(1):107-16. PubMed ID: 21117032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
    Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
    J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paracrine role for TGF-β-induced CTGF and VEGF in mesangial matrix expansion in progressive glomerular disease.
    Lee HS
    Histol Histopathol; 2012 Sep; 27(9):1131-41. PubMed ID: 22806900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory smads and tgf-Beta signaling in glomerular cells.
    Schiffer M; Schiffer LE; Gupta A; Shaw AS; Roberts IS; Mundel P; Böttinger EP
    J Am Soc Nephrol; 2002 Nov; 13(11):2657-66. PubMed ID: 12397035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructural features and expression of cytoskeleton proteins of podocyte from patients with minimal change disease and focal segmental glomerulosclerosis.
    Shi SF; Wang SX; Zhang YK; Zhao MH; Zou WZ
    Ren Fail; 2008; 30(5):477-83. PubMed ID: 18569926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis.
    Daehn I; Casalena G; Zhang T; Shi S; Fenninger F; Barasch N; Yu L; D'Agati V; Schlondorff D; Kriz W; Haraldsson B; Bottinger EP
    J Clin Invest; 2014 Apr; 124(4):1608-21. PubMed ID: 24590287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the TGF-beta/Smad signaling pathway in focal segmental glomerulosclerosis.
    Kim JH; Kim BK; Moon KC; Hong HK; Lee HS
    Kidney Int; 2003 Nov; 64(5):1715-21. PubMed ID: 14531804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.
    Suzuki K; Wilkes MC; Garamszegi N; Edens M; Leof EB
    Cancer Res; 2007 Apr; 67(8):3673-82. PubMed ID: 17440079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta signal transduction and mesangial cell fibrogenesis.
    Schnaper HW; Hayashida T; Hubchak SC; Poncelet AC
    Am J Physiol Renal Physiol; 2003 Feb; 284(2):F243-52. PubMed ID: 12529270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of podocyte damage in the pathogenesis of glomerulosclerosis and possible repair mechanisms].
    Ronconi E; Mazzinghi B; Sagrinati C; Angelotti ML; Ballerini L; Parente E; Romagnani P; Lazzeri E; Lasagni L
    G Ital Nefrol; 2009; 26(6):660-9. PubMed ID: 19918748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,25-Dihydroxyvitamin D(3) prevents puromycin aminonucleoside-induced apoptosis of glomerular podocytes by activating the phosphatidylinositol 3-kinase/Akt-signaling pathway.
    Xiao H; Shi W; Liu S; Wang W; Zhang B; Zhang Y; Xu L; Liang X; Liang Y
    Am J Nephrol; 2009; 30(1):34-43. PubMed ID: 19202327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of podocyte phenotype in collapsing glomerulopathies.
    Barisoni L; Kopp JB
    Microsc Res Tech; 2002 May; 57(4):254-62. PubMed ID: 12012394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-β/BMP pathways and the podocyte.
    Tossidou I; Schiffer M
    Semin Nephrol; 2012 Jul; 32(4):368-76. PubMed ID: 22958491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podocyte hypertrophy, "adaptation," and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction.
    Wiggins JE; Goyal M; Sanden SK; Wharram BL; Shedden KA; Misek DE; Kuick RD; Wiggins RC
    J Am Soc Nephrol; 2005 Oct; 16(10):2953-66. PubMed ID: 16120818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of disease: focal segmental glomerulosclerosis.
    Meyrier A
    Nat Clin Pract Nephrol; 2005 Nov; 1(1):44-54. PubMed ID: 16932363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.